(Q84109861)
Statements
Efficacy and safety results from a phase III, randomized controlled trial comparing the safety and efficacy of briakinumab with etanercept and placebo in patients with moderate to severe chronic plaque psoriasis (English)
B E Strober
J J Crowley
P S Yamauchi
M Olds